Figure. Oral Antiviral or Monoclonal Antibody Use for COVID-19 in US Nursing Homes.
A, Data from the National Healthcare Safety Network (NHSN) database from 15 092 nursing homes. B, Moving 6-week average of Winsorized weekly treatment rates. Monoclonal antibodies include bamlanivimab, casirivimab plus imdevimab, bamlanivimab plus etesevimab, sotrovimab, and bebtelovimab. The NHSN data do not contain information on the use of remdesivir.